Abstract
Purpose :
Dominant cone-rod homeobox (CRX)-associated Leber congenital amaurosis (LCA7) is a severe retinal degenerative disease for which no treatments are currently available. Disease-causing variants in CRX typically result in the production of a dominant negative form of the protein, which disrupts normal photoreceptor maturation. To gain further insight into LCA7, we aimed to establish an in vitro model system to investigate CRX variant-specific disease mechanisms.
Methods :
Human iPSC lines were generated from LCA7 patient whole blood samples, which harbor dominant mutations in CRX (CRXT155ins4/+ and CRXK88Q/+). The patient-derived hiPSC lines were differentiated to generate retinal organoids, and immunohistochemistry, TEM, qPCR, and single-cell RNA sequencing were utilized to characterize photoreceptor cell development and maturation up to day 240 (D240) of differentiation.
Results :
Retinal organoids were successfully generated from patient iPSCs, and both lines exhibit retinal tissue thickness and photoreceptor cell numbers comparable to those of CRXWT organoids throughout differentiation. Morphologically, both CRXT155ins4/+ and CRXK88Q/+ organoids remain identical to CRXWT until D240, when they fail to develop outer segments, similar to what has been reported in LCA7 patients and mouse models. Although both CRXT155ins4/+ and CRXK88Q/+ organoids exhibit similar levels of OTX2 protein and mRNA compared to control, CRXT155ins4/+ organoids show an increase in total CRX, while CRXK88Q/+ organoids show a decrease. CRXT155ins4/+ and CRXK88Q/+ organoids both reveal a reduction in RCVRN, AIPL1, ARR3, RHO, OPN1SW, OPN1MW, and OPN1LW compared to CRXWT organoids (p<0.05), suggesting a decrease in expression of key photoreceptor genes. Variant-specific differences in levels of NRL, NR2E3, SAG, and cone opsins were also observed through D240 of differentiation, highlighting intriguing differences in disease mechanisms between variants.
Conclusions :
Here, we have established an early photoreceptor cell-specific LCA phenotype in our patient organoids, and these data provide promise for a reliable in vitro model system which can be used to study variant-specific disease mechanisms. Future work will focus on studying disease mechanisms and therapeutic approaches in our organoid model system.
This is a 2021 ARVO Annual Meeting abstract.